Indian journal of psychiatry · 2026
Magnetic seizure therapy for severe depressive episodes: An open-label case series.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shibu Aromal, Pathak Harsh, Sreeraj Vanteemar S, Mehta Urvakhsh Meherwan, Sinha Preeti, Arumugham Shyam Sundar, Thirthalli Jagadisha
Аннотация
BACKGROUND: Magnetic seizure therapy (MST) is a potential alternative to electroconvulsive therapy (ECT) with a favorable cognitive adverse effect profile.
CASES: We present the first report of MST administration in India on six patients with severe depressive episodes referred for convulsive therapy. MST was administered thrice weekly under general anesthesia. Four of six patients achieved remission following MST (mean 8.5 sessions per patient, range 7-13). No clinically meaningful cognitive decline occurred; reorientation was consistently rapid with mild self-limiting adverse effects.
CONCLUSION: MST was feasible and safe within the existing ECT infrastructure, with meaningful clinical effectiveness, and preserved cognitive function.
CASES: We present the first report of MST administration in India on six patients with severe depressive episodes referred for convulsive therapy. MST was administered thrice weekly under general anesthesia. Four of six patients achieved remission following MST (mean 8.5 sessions per patient, range 7-13). No clinically meaningful cognitive decline occurred; reorientation was consistently rapid with mild self-limiting adverse effects.
CONCLUSION: MST was feasible and safe within the existing ECT infrastructure, with meaningful clinical effectiveness, and preserved cognitive function.